ResMed RMD Income Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $1.4B+37.2% | $1.02B+13.7% | $897.56M+15.2% | $779.44M+64.3% | ||
| $1.88B+25.9% | $1.5B+15.4% | $1.3B+11.8% | $1.16B+9.4% | ||
| $1.69B+27.7% | $1.32B+16.6% | $1.13B+13.2% | $1B+10.7% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is ResMed's revenue?
- ResMed (RMD) generated $5.5B in revenue over the trailing twelve months, up 10.3% year over year.
- Is ResMed profitable?
- ResMed reported $1.5B in net income over the trailing twelve months, a 27.4% net margin.
- What are ResMed's profit margins?
- Gross margin is 61.6% and operating margin is 34.2%, with a 27.4% net margin.
- What is ResMed's earnings per share?
- ResMed's diluted EPS over the trailing twelve months is $10.37.
- Where does ResMed's income statement data come from?
- Every line is extracted from ResMed's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
